Sandip Pravin Patel - Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center

基本信息

Career Trajectory

Bio

Medical Oncologist in the Cancer Immunotherapy, Experimental Therapeutics (Phase 1), and Thoracic Oncology Programs. UCSD Moores Cancer Center Focus on early phase clinical trials involving immunotherapy, immunomodulation, solid tumor cellular therapy. Interest in phase 1 immunotherapy trials and thoracic oncology immunotherapy trials.

Research Interests

Papers共 359 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Intratumoral or Subcutaneous MK-2118, a Non-Cyclic Dinucleotide STING Agonist, with or Without Pembrolizumab for Advanced or Metastatic Solid Tumors or Lymphomas

Jason J Luke,Randy F Sweis,J Randolph Hecht,Reva Schneider,Mark N Stein,Talia Golan,Timothy A Yap,Anuradha Khilnani,Mo Huang, Runchen Zhao,Thomas Jemielita,Sandip Pravin Patel

Clinical cancer research an official journal of the American Association for Cancer Researchno. 7 (2025): 1233-1242

Cited0Views0WOSBibtex

Correlation of Mesothelin (MSLN) Expression Measured by RNA Sequencing (rnaseq) and Immunohistochemistry (IHC) in MSLN-expressing Tumors

Joel R. Hecht,Patrick Grierson,Theodore H. Welling III,Kristen Renee Spencer, Antonious Ziad Hazim,Jong Chul Park,Matthew Ulrickson,Kedar Kirtane,Hemant S. Murthy,Sandip Pravin Patel,Jennifer M. Specht,Wen-Kai Weng,Marcela Valderrama Maus,David G. Maloney, Eric Wai-Choi Ng,Julian R. Molina,Armen Mardiros,Maria Pia Morelli,John Sutton Welch, Diane M. Simeone

JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2025): 766-766

Cited0Views0Bibtex

Validation of an Updated Algorithm to Identify Patients with Incident Non-Small Cell Lung Cancer in Administrative Claims Databases

Sandip Pravin Patel,Rongrong Wang,Summera Qiheng Zhou,Daniel Sheinson,Ann Johnson,Janet Shin Lee

JCO Clinical Cancer Informatics（2024）

Cited0Views0WOSBibtex

Supplementary Table S2 from SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

Young Kwang Chae,Megan Othus,Sandip Pravin Patel,Kelly J. Wilkinson, Emily M. Whitman-Purves,Jayanthi Lea, John M. Schallenkamp,Nabil Adra,Leonard J. Appleman, Mitchell Alden, Jessica Thomes Pepin, John A. Ellerton,Andrew Poklepovic,Adam Walter,Murtuza M. Rampurwala,William R. Robinson,Hye Sung Kim,Liam Il-Young Chung,Christine M. McLeod,Gabby Lopez,Helen X. Chen,Elad Sharon,Howard Streicher,Christopher W. Ryan,Charles D. Blanke,Razelle Kurzrock

crossref（2024）

Cited0Views0Bibtex

Correlations Between First Cycle Toxicity and Overall Survival in Patients with Rare Cancers Treated with Immune Checkpoint Inhibitors (NCI/SWOG S1609)

Megan Othus,Sandip Pravin Patel,Young Kwang Chae,Eliana Dietrich,Howard Streicher,Elad Sharon,Razelle Kurzrock

Journal of Clinical Oncology（2024）

Cited0Views0Bibtex

P4.11D.01 TRITON: Tremelimumab + Durvalumab + Chemotherapy (CT) Vs Pembrolizumab + CT in Mnsclc with STK11, KEAP1 And/or KRAS Mutations

F. Skoulidis,H. Borghaei,E.B. Garon,T.A. Leal,J. Kaufman,S.V. Liu, E. Nadler,S.P. Patel,S. Peters,V. Velcheti, A. Gautam,U. Emeribe, L. Luciani-Silverman,J.V. Heymach

Journal of Thoracic Oncologyno. 10 (2024): S389

Cited0Views0Bibtex

Supplementary Table S1 from SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

crossref（2024）

Cited0Views0Bibtex

Immuno-Oncology

Shiruyeh Schokrpur,Michael G. White,Christina L. Roland,Sandip Pravin Patel

Surgical Oncology Clinics of North Americano. 2 (2024): 265-278

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn